Maximal STAT5-Induced Proliferation and Self-Renewal at Intermediate STAT5 Activity Levels
暂无分享,去创建一个
[1] E. Vellenga,et al. Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases. , 2008, Experimental hematology.
[2] N. Andrews,et al. Hematopoietic-specific Stat5-null mice display microcytic hypochromic anemia associated with reduced transferrin receptor gene expression. , 2008, Blood.
[3] U. Klingmüller,et al. Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2. , 2008, Blood.
[4] L. Hennighausen,et al. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. , 2008, Genes & development.
[5] Jinshui Fan,et al. Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML. , 2008, Blood.
[6] L. Hennighausen,et al. STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output. , 2007, Experimental hematology.
[7] E. Vellenga,et al. Erratum in Schepers et al. Reintroduction of C/EBPα in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis. , 2007, Blood.
[8] R. Humphries,et al. Hox genes in hematopoiesis and leukemogenesis , 2007, Oncogene.
[9] E. Vellenga,et al. STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells. , 2007, Blood.
[10] W. Kamps,et al. Evidence Based Selection of Housekeeping Genes , 2007, PloS one.
[11] E. Vellenga,et al. Reintroduction of C/EBPalpha in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis. , 2007, Blood.
[12] S. Oliviero,et al. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation , 2007, Nature Cell Biology.
[13] K. D. Bunting,et al. STAT5 signaling in normal and pathologic hematopoiesis. , 2007, Frontiers in bioscience : a journal and virtual library.
[14] G. Morrone,et al. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. , 2007, Experimental hematology.
[15] C. Pecquet,et al. Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias. , 2007, Blood.
[16] M. Nostro,et al. Notch Signaling Induces Apoptosis in Primary Human CD34+ Hematopoietic Progenitor Cells , 2007, Stem cells.
[17] Frédérick A. Mallette,et al. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. , 2007, Genes & development.
[18] R. V. van Etten,et al. Molecular Pathogenesis and Therapy of Polycythemia Induced in Mice by JAK2 V617F , 2006, PloS one.
[19] H. Cavé,et al. Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. , 2006, Blood.
[20] B. Porse,et al. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block , 2006, Nature Immunology.
[21] W. Vainchenker,et al. JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis. , 2006, Blood.
[22] L. Hennighausen,et al. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. , 2006, Blood.
[23] R. Ilaria,et al. STAT5 signaling is required for the efficient induction and maintenance of CML in mice. , 2006, Blood.
[24] R. Levine,et al. Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. , 2006, Blood.
[25] R. McKay,et al. Notch controls proliferation and differentiation of stem cells in a dose‐dependent manner , 2006, The European journal of neuroscience.
[26] A. Ganser,et al. Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML). , 2006, Blood.
[27] S. Bohlander,et al. Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations , 2006, The Journal of experimental medicine.
[28] E. Vellenga,et al. STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha. , 2005, Blood.
[29] F. Rosenbauer,et al. Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. , 2006, Nature immunology.
[30] S. Chiba,et al. Notch Signaling in Hematopoietic Stem Cells , 2005, International journal of hematology.
[31] K. Akashi,et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. , 2005, Blood.
[32] S. Akira,et al. Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis , 2005, The Journal of experimental medicine.
[33] Andreas Trumpp,et al. More than just proliferation: Myc function in stem cells. , 2005, Trends in cell biology.
[34] E. Wagner,et al. Stat5 tetramer formation is associated with leukemogenesis. , 2005, Cancer cell.
[35] G. Morrone,et al. Enforced expression of an Flt3 internal tandem duplication in human CD34+ cells confers properties of self-renewal and enhanced erythropoiesis. , 2005, Blood.
[36] Pu Zhang,et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. , 2004, Immunity.
[37] G. Morrone,et al. Enforced Activation of STAT5A Facilitates the Generation of Embryonic Stem–Derived Hematopoietic Stem Cells That Contribute to Hematopoiesis In Vivo , 2004, Stem cells.
[38] O. Silvennoinen,et al. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. , 2004, Cytokine & growth factor reviews.
[39] Giovanni Morrone,et al. Constitutive Activation of STAT5A Promotes Human Hematopoietic Stem Cell Self-Renewal and Erythroid Differentiation , 2004, The Journal of experimental medicine.
[40] J. Kutok,et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1 , 2004, Nature Genetics.
[41] C. Couldrey,et al. Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness. , 2004, Blood.
[42] L. Staudt,et al. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. , 2004, Cancer cell.
[43] M. Goldsmith,et al. Bone marrow transplant completely rescues hematolymphoid defects in STAT5A/5B-deficient mice. , 2003, Experimental hematology.
[44] M. Goldsmith,et al. Transgenic bcl-2 is not sufficient to rescue all hematolymphoid defects in STAT5A/5B-deficient mice. , 2003, Experimental hematology.
[45] I. Weissman,et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.
[46] J. Lammers,et al. Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells. , 2003, Blood.
[47] Bob Löwenberg,et al. Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML. , 2003, The hematology journal : the official journal of the European Haematology Association.
[48] T. Hawley,et al. Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. , 2002, Blood.
[49] W. Hiddemann,et al. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells. , 2002, Experimental hematology.
[50] J. Ihle,et al. Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5. , 2002, Blood.
[51] M. Goldsmith,et al. STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells. , 2002, Blood.
[52] H. Lodish,et al. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. , 2001, Blood.
[53] J. Ihle. The Stat family in cytokine signaling. , 2001, Current opinion in cell biology.
[54] Pu Zhang,et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia , 2001, Nature Genetics.
[55] E. Vellenga,et al. Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts , 2000, Leukemia.
[56] C. Mantel,et al. Chemokines, chemokine receptors and hematopoiesis , 2000, Immunological reviews.
[57] M. Roussel,et al. Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5. , 2000, Blood.
[58] W. Leonard,et al. Essential Role of Signal Transducer and Activator of Transcription (Stat)5a but Not Stat5b for Flt3-Dependent Signaling , 2000, The Journal of experimental medicine.
[59] M. Loh,et al. Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. , 2000, Molecular cell.
[60] A. Mui,et al. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells , 1999, The EMBO journal.
[61] H. Lodish,et al. Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice A Direct Role for Stat5 in Bcl-XL Induction , 1999, Cell.
[62] J. Ryan,et al. Stem cell factor activates STAT-5 DNA binding in IL-3-derived bone marrow mast cells. , 1997, Experimental hematology.
[63] R. V. van Etten,et al. P210 and P190BCR/ABL Induce the Tyrosine Phosphorylation and DNA Binding Activity of Multiple Specific STAT Family Members* , 1996, The Journal of Biological Chemistry.
[64] C. Sawyers,et al. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. , 1996, Oncogene.
[65] J. Griffin,et al. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl , 1996, The Journal of experimental medicine.
[66] B. Groner,et al. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. , 1996, Blood.
[67] B. Groner,et al. Interleukin-3, Erythropoietin, and Prolactin Activate a STAT5-like Factor in Lymphoid Cells (*) , 1995, The Journal of Biological Chemistry.
[68] D. Levy,et al. Thrombopoietin activates a STAT5‐like factor in hematopoietic cells. , 1995, The EMBO journal.
[69] H. Erdjument-Bromage,et al. Interleukin‐3 signals through multiple isoforms of Stat5. , 1995, The EMBO journal.
[70] A. Miyajima,et al. Interleukin‐3, granulocyte‐macrophage colony stimulating factor and interleukin‐5 transduce signals through two STAT5 homologs. , 1995, The EMBO journal.
[71] J. Darnell,et al. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.
[72] A. Berns,et al. Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors , 1989, Cell.